Psychoeducation Intervention for Caregivers of Children With Cancer

Status Completed

Clinical Trial Summary

This randomized controlled trial aims to evaluate the effectiveness of the psychoeducation intervention on anxiety, depressive symptoms, coping, and HRQoL in caregivers of children with cancer. The study is a two-arm parallel-group single-blind, randomized controlled trial that will be conducted in two hospitals in Malawi.

Clinical Trial Description

Aim of the study To develop and implement psychoeducation intervention that meet the need of caregivers of children with cancer in Malawi. Objectives of the study 1. To develop a psychoeducation intervention that addresses the needs of caregivers of children with cancer in Malawian culture. 2. To evaluate the effectiveness of the PEI in reducing anxiety and depressive symptoms and enhancing coping and HRQoL among caregivers of children with cancer in Malawi. Hypotheses of the study 1. Compared with the control group, caregivers in the intervention group will have significantly lower anxiety levels immediately after the intervention, and at 3 months post-intervention. 2. Compared with the control group, caregivers in the intervention group will have significantly fewer depressive symptoms immediately after the intervention, and at 3 months post-intervention. 3. Compared with the control group, caregivers in the intervention group will have significantly better HRQoL, immediately after the intervention, and at 3 months post-intervention. 4. Compared with the control group, caregivers in the intervention group will have significantly better coping skills immediately after the intervention, and at 3 months post-intervention. ;

Study Design

Related Conditions & MeSH terms

Pediatric Cancer

Clinical Trial Details

NCT number	NCT05783310
Study type	Interventional
Source	Chinese University of Hong Kong
Contact
Status	Completed
Phase	N/A
Start date	May 22, 2023
Completion date	December 30, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04262830` - Cancer Therapy Effects on the Heart
Not yet recruiting	`NCT06335745` - PediCARE Health Equity Intervention in High-Risk Neuroblastoma	N/A
Withdrawn	`NCT04719416` - Relaxation Therapy in Pediatric Oncology	N/A
Completed	`NCT01645436` - Physical Activity in Pediatric Cancer (PAPEC)	N/A
Completed	`NCT04409301` - Distress in the Pediatric Oncology Setting: Intervention Versus Natural Adaptation	N/A
Completed	`NCT04914702` - Feasibility and Comparison of Continuously Monitored Vital Signs in Pediatric Patients With Cancer.
Recruiting	`NCT05425043` - Granulocyte Transfusions After Umbilical Cord Blood Transplant	N/A
Recruiting	`NCT05071859` - Genetic Overlap Between Anomalies and Cancer in Kids in the Children's Oncology Group: The COG GOBACK Study
Recruiting	`NCT03241251` - Screening for Psychosocial Risk in Flemish Families of a Child With Cancer
Recruiting	`NCT05384288` - Response to Influenza Vaccination in Pediatric Oncology Patients
Completed	`NCT04586491` - The Effect of Oral Care Protocol on Prevention of Oral Mucositis in Pediatric Cancer Patients	N/A
Recruiting	`NCT05569512` - Uproleselan With Pre-Transplant Conditioning in Hematopoietic Stem Cell Transplantation for AML	Phase 1/Phase 2
Enrolling by invitation	`NCT05294380` - Determination of Sarcopenia Risk and Related Factors in Pediatric Oncological Patients
Completed	`NCT02675166` - Getting Long-term Management of Adult Children Cured of Childhood Cancer in Rhône-Alpes
Completed	`NCT02665819` - Long Term Support for Pediatric Cancer Adult Survivors in Rhône-Alpes : Evaluation of Women Fertility.	N/A
Not yet recruiting	`NCT05454163` - Post-radiotherapy Rhinosinusitis in Children
Terminated	`NCT02536183` - A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors	Phase 1
Withdrawn	`NCT01828502` - Cotinine Feedback as an Intervention to Change Parental/Caregiver Smoking Behavior Around Children With Cancer	Phase 2
Completed	`NCT02032121` - Vascular Endothelial Inflammation and Dysfunction in Pediatric Long-term Cancer Survivors	N/A
Completed	`NCT03964259` - Reduced IV Fluids to Improve Clearance of HDMTX in Children w/Lymphoma or Acute Lymphoblastic Leukemia	Phase 1